EZH2 expression in invasive lobular carcinoma of the breast. - Wikidata - wikimedia - TriplyDB

EZH2 expression in invasive lobular carcinoma of the breast.

EZH2 expression in invasive lobular carcinoma of the breast.

http://www.wikidata.org/entity/Q34462723

about

Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy Prognostic role of YB-1 expression in breast cancer: a meta-analysis Significance of EZH2 expression in canine mammary tumors.Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions.Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran.

P2860

Q27853296-A28346E2-3C89-4149-8259-5F0B89EBF1E0 Q34175876-AD78FAD4-5BC8-4B39-A768-547926FA6CFE Q35479413-95A113FB-EC62-49A7-A7B9-695ABB58F52E Q36098022-7337C0BD-6256-4684-9F58-CABD50D837D4 Q38253055-5A9B0528-34C8-422C-8124-3E721D1DF9E6 Q41721647-FD698BDB-A733-430E-9858-67452F6D2BF1 Q49344192-A917599B-25FB-4EE4-BEC1-ACD2623D99A3

P2860

EZH2 expression in invasive lobular carcinoma of the breast.

http://www.wikidata.org/entity/Q34462723

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

EZH2 expression in invasive lobular carcinoma of the breast.

@ast

EZH2 expression in invasive lobular carcinoma of the breast.

@en

EZH2 expression in invasive lobular carcinoma of the breast.

@nl

type

label

EZH2 expression in invasive lobular carcinoma of the breast.

@ast

EZH2 expression in invasive lobular carcinoma of the breast.

@en

EZH2 expression in invasive lobular carcinoma of the breast.

@nl

prefLabel

EZH2 expression in invasive lobular carcinoma of the breast.

@ast

EZH2 expression in invasive lobular carcinoma of the breast.

@en

EZH2 expression in invasive lobular carcinoma of the breast.

@nl

P1433

Q34462723-4F280A13-DA98-4313-A2CD-CDA87C1829C3

P1476

Q34462723-AAD99965-6BE4-41BA-A4FC-C8E186FFDE6F

P2093

Q34462723-029B6366-6848-422B-86F5-B42A1D501207

Q34462723-749EEC43-E8C9-4590-B44E-3871A017F433

Q34462723-A36AFEEC-D2D4-4D0E-994F-210C33BBD903

Q34462723-CB54C079-F3DB-42AF-89C2-5FC89652BE7E

Q34462723-DD459231-4A19-4020-BB80-527824C144CD

P2860

Q34462723-085CB5DB-0085-4D5E-B7CE-787112DB9E08

Q34462723-18AF4C75-306A-400B-909A-9EF134407BCB

Q34462723-2A6241AC-0398-464F-9A26-6416EE9A2474

Q34462723-42E624A7-A5BF-4B9F-9909-EC7E5BD8B077

Q34462723-457AA4DE-F515-430E-ABCF-D4448BE21BB0

Q34462723-5A4E01E3-E600-4A3F-B588-3CAD22C1C9F0

Q34462723-7E8B2982-77DB-4938-8D3F-0366F9BFD95E

Q34462723-8515DAF3-9AF7-40AE-A56C-6DBA0036E810

Q34462723-89FF99FB-129D-499F-93C7-53EDCE74A468

Q34462723-8DB49EC9-E5CF-4D69-8E3D-697B4CE5024C

P2888

Q34462723-C5EEB723-88F7-4882-8F62-B0664735B10B

P304

Q34462723-851C3422-47C1-4B0C-AD32-E39D05BF33FD

P31

Q34462723-F9497E42-D5DB-4485-B155-6A8561DB2660

P356

Q34462723-0A232E83-B271-480A-A174-81C2CD8D555D

P478

Q34462723-B25A72B7-0D88-49B8-98A3-E62DF09934A9

P577

Q34462723-4E54D8CE-CE7F-40C7-AA95-A0B2CF3BE968

P5875

Q34462723-D238028E-B3C3-41CA-9078-BFE330D559A7

P6179

Q34462723-997EDE1A-A95B-426E-A8DC-DC58C0ABF2EF

P698

Q34462723-287E61AA-815E-4E28-8549-6E925109F55C

P932

Q34462723-6C2607C7-2097-4CCF-8A3D-BE8FB74061E4

P356

1477-7819-11-299

P1433

World Journal of Surgical Oncology

P1476

EZH2 expression in invasive lobular carcinoma of the breast.

@en

P2093

Eun Jung Cha

http://www.w3.org/2001/XMLSchema#string

Hyoung Suk Ko

http://www.w3.org/2001/XMLSchema#string

Jang Sihn Sohn

http://www.w3.org/2001/XMLSchema#string

Shin Young Park

http://www.w3.org/2001/XMLSchema#string

SiGyun Roh

http://www.w3.org/2001/XMLSchema#string

P2860

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

The Polycomb group protein EZH2 directly controls DNA methylation

EZH2 methyltransferase and H3K27 methylation in breast cancer

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

The polycomb group protein EZH2 is involved in progression of prostate cancer

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression

Invasive pleomorphic lobular carcinoma of the breast: clinicopathologic characteristics and prognosis compared with invasive ductal carcinoma

Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1

P2888

1477-7819-11-299

P304

299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7819-11-299

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258851093

http://www.w3.org/2001/XMLSchema#string

P6179

1036629957

http://www.w3.org/2001/XMLSchema#string

P698

24266940

http://www.w3.org/2001/XMLSchema#string

P932

4222266

http://www.w3.org/2001/XMLSchema#string